檢索結果 - CQ Deng
- Showing 1 - 2 results of 2
-
1
Study design and rationale for the TETON phase 3, randomised, controlled clinical trials of inhaled treprostinil in the treatment of idiopathic pulmonary fibrosis 由 Steven D. Nathan, Jürgen Behr, Vincent Cottin, Lisa Lancaster, Peter Smith, CQ Deng, Natalie Pearce, Heidi Bell, Leigh Peterson, Kevin R. Flaherty
出版 2022Artigo -
2
Novel composite clinical endpoints and risk scores used in clinical trials in pulmonary arterial hypertension 由 Sitbon, Olivier, Nikkho, Sylvia, Benza, Raymond, (CQ) Deng, Chunqin, Farber, Harrison W., Gomberg-Maitland, Mardi, Hassoun, Paul, Meier, Christian, Pepke-Zaba, Joanna, Prasad, Krishna, Seeger, Werner, Corris, Paul A
出版 2020Text
相關主題
Adverse effect
Clinical endpoint
Clinical trial
Data monitoring committee
Diffusing capacity
Exacerbation
Guideline
Idiopathic pulmonary fibrosis
Intensive care medicine
Internal medicine
Interstitial lung disease
Lung
Lung function
Medicine
Nintedanib
Pathology
Pirfenidone
Pulmonary hypertension
Treprostinil
Vital capacity